Dr Cartier-Lacave is a research director at INSERM, where she leads the group "Biotherapies
of neurodegenerative diseases." Dr Cartier-Lacave is president of the European Society of Gene and Cell Therapy (ESGCT).
Contract notice: upgrade of a water treatment plant at the center for biology pathology and acquisition of one or two compact water units for dishwashers in the service of biotherapies
, maintenance and associated consumables
Be The Match BioTherapies
and Cryoport announced a strategic partnership to deliver end-to-end supply chain services to the cell and gene therapy industry.
He has also chaired the start-up Genosafe and launched the Institute of Biotherapies
for Rare Diseases.
24 January 2018 - Minnesota, US-based cellular therapy solutions organisation Be The Match BioTherapies
has invested in Pennsylvania, US-based clinical-stage biotherapeutics company Tmunity Therapeutics to support advancement of next-generation T cell iummunotherapies, the company said.
Altacor, an ophthalmic product specialist, and NuVision Biotherapies
, a regenerative wound treatment company, have announced the signing of a strategic partnership to distribute the sight-saving therapy, Omnigen, in England, Scotland and Wales.
Immunogenicity of anti-TNF-[alpha] biotherapies
They research, develop, manufacture and market biotherapies
, which are used to treat serious and rare conditions, including coagulation (bleeding) disorders such as haemophilia and von Willebrand disease and immune deficiencies.
Poland is the chair of a safety evaluation committee for novel investigational vaccine trials being conducted by Merck, and he offers consultative advice on vaccine development to Merck, CSL Biotherapies
, Avianax, Dynavax, Novartis, Emergent BioSolutions, Adjuvance, Microdermis, Seqirus, NewLink, Protein Sciences, GlaxoSmithKline, and Sanofi Pasteur.
"This partnership marks a significant change in how pharmaceutical companies view theranostics and is a formidable opportunity to promote the monitoring of biotherapies
. For the first time, a pharmaceutical company will be pairing our monitoring kits with their treatments.
are increasingly more sophisticated, the tools for delivering regenerative therapies demonstrate a limited capacity in achieving high cell retention in the heart," said Atta Behfar, a cardiology specialist and lead author of the study.
As a member of the Atlanpole Biotherapies
cluster, the company was spun out of the Institute for Transplantation Urology, Nephrology (ITUN, Europe's leading centre for kidney and combined kidney/pancreas transplantation) in December 2007.